Code | 9996D | ||||||||||
MA number | 41/0074/22-S | ||||||||||
Product Form: | con inf 1x5 ml/12,5 mg (liek.skl.inj.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 41 - CARDIACA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 30.03.2022 |
Validity: | 30.03.2027 |
Pediatric warnings: | Yes |
SPC: | SPC_Levosimendan Zentiva_con inf_08_2022.pdf |
PIL: | PIL_Levosimendan Zentiva_con inf_11_2023.pdf |
Safety feature | Yes |
Data update: | 31.03.2022 |